Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05250622
Other study ID # 13493
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 8, 2022
Est. completion date July 29, 2022

Study information

Verified date July 2022
Source McMaster University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this randomized controlled trial is to clarify whether providing translated evidence summary (Advanced Clinical Evidence (ACE) reports from OrthoEvidence) will increase the access to the summary compared to providing the original version of evidence summary among Japanese orthopaedic surgeons


Description:

The investigators will conduct the survey regarding baseline characteristics, barriers and familiality to evidence-based medicine by online. After the survey, the participants will be randomly assigned to receive either the original version of ACE reports or Japanese version of ACE reports. The pdf of each ACE report will be provided to the participants through an email link. Twenty reports will be sent over 4 weeks period. After that, the investigators will conduct another survey regarding the reports.


Recruitment information / eligibility

Status Completed
Enrollment 105
Est. completion date July 29, 2022
Est. primary completion date July 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: 1. Member of Japanese Society for Fracture Repair (JSFR) 2. Spend at least 20% of their time in clinical practice 3. Non-native speaker of English 4. Has regular access to internet 5. Prefer to read Japanese-translated material, if there are both translated and English version of the same material. Exclusion Criteria: We will exclude surgeons who cannot provide informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Japanese-translated evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
Participants will receive emails with the link to Japanese-translated version of evidence summaries.
English evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
Participants will receive emails with the link to English version of evidence summaries.

Locations

Country Name City State
Canada McMaster University Hamilton Ontario

Sponsors (3)

Lead Sponsor Collaborator
McMaster University Japanese Society for Fracture Repair, OrthoEvidence

Country where clinical trial is conducted

Canada, 

References & Publications (3)

Dahm P, Poolman RW, Bhandari M, Fesperman SF, Baum J, Kosiak B, Carrick T, Preminger GM; American Urological Association Membership. Perceptions and competence in evidence-based medicine: a survey of the American Urological Association Membership. J Urol. 2009 Feb;181(2):767-77. doi: 10.1016/j.juro.2008.10.031. Epub 2008 Dec 16. — View Citation

Poolman RW, Sierevelt IN, Farrokhyar F, Mazel JA, Blankevoort L, Bhandari M. Perceptions and competence in evidence-based medicine: Are surgeons getting better? A questionnaire survey of members of the Dutch Orthopaedic Association. J Bone Joint Surg Am. 2007 Jan;89(1):206-15. — View Citation

Sprague S, Smith C, Bhandari M. OrthoEvidence™: A Clinical Resource for Evidence-Based Orthopedics. Orthop Rev (Pavia). 2015 Jun 3;7(2):5762. doi: 10.4081/or.2015.5762. eCollection 2015 Jun 3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of access to evidence summaries Total number of access to evidence summaries Four weeks (28 days) after the commencement of the trial
Secondary Self-rated score of understanding the contents of the provided materials Five-point Likert scale in understanding the contents of provided materials, evaluated by the participants (higher scores means better outcome) Within four weeks after the end of intervention
Secondary Self-rated score in changing their practice based on the contents of the materials Five-point Likert scale in changing their practice based on the contents of the materials evaluated by the participants (higher scores means better outcome) Within four weeks after the end of intervention
See also
  Status Clinical Trial Phase
Completed NCT06326723 - Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects Phase 1
Recruiting NCT00001367 - Diagnosis and History Study of Patients With Different Neurological Conditions
Completed NCT02699710 - Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy Subjects Phase 1
Completed NCT02231892 - Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study N/A
Not yet recruiting NCT06441916 - Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions Phase 1
Completed NCT03771586 - A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects Phase 1
Not yet recruiting NCT06337422 - Bioequivalence Study of Generic Celecoxib 200 mg Capsules Phase 1
Completed NCT03302182 - Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects Phase 1
Completed NCT05049343 - Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants Phase 1
Recruiting NCT01629108 - Normal Values in Hearing and Balance Testing
Completed NCT02947854 - Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant Phase 1
Completed NCT02534870 - Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects Phase 1
Completed NCT02224053 - Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers Phase 1
Completed NCT01711762 - A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers Phase 1
Completed NCT01676584 - A Study of Single Dose RO6811135 in Healthy Volunteers Phase 1
Completed NCT01697436 - A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus Tablets Phase 1
Completed NCT01684891 - A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers Phase 1
Completed NCT01579149 - A Phase I Dose Escalation Study of Plerixafor in Healthy Subjects of Japanese Descent Phase 1
Completed NCT02547259 - Influence of Emotion in a Test Run Forgetfulness N/A
Completed NCT01414881 - Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects Phase 1